CEO will appear on the On The Move show to discuss Company’s technology as a high-tech alternative to vaping devices, why the GCANRx patch is safer, and what’s in the pipeline for the future.
BALTIMORE, MD, Sept. 23, 2019 (GLOBE NEWSWIRE) -- The Greater Cannabis Company, Inc. (OTCQB: GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, is scheduled to be featured in a live interview today at 12:40pm EST on the Yahoo Finance News Network’s On The Move Show. During today’s segment, the Company’s Chief Executive Officer, Aitan Zacharin, is expected to discuss the GCANRx delivery technology as a high-tech alternative to vaping devices and other methods of administration of cannabis, why the GCANRx patch is safer, how it differs from other delivery systems, and how it works. He will also highlight the Company’s plans for commercialization, and what’s in the pipeline for the future.
Please note the interview can be viewed on the Yahoo Finance website, which can be found at this link https://finance.yahoo.com/show/onthemove. A recording of the interview will be available shortly after on the Company’s website.
Sales of vaping products- the fastest-growing segment of the flourishing cannabis market- are falling nationwide amid reports of hundreds of patients experiencing lung ailments, the majority of which have been linked to vaping cannabis products. The Centers for Disease Control (CDC) is advising consumers to avoid using e-cigarette products while they investigate to try and find a cause for the illness that has stricken 530 people, and has caused eight deaths.
“It’s sad to see how consumers looking to use cannabis are falling victim to dangerous delivery systems such as vaping.” said Aitan Zacharin, Chief Executive Officer of The Greater Cannabis Company. “Smoking has been known for decades to be detrimental to our health, and now with the high demand for cannabis, for some reason, that knowledge has taken a back seat.” he added. “Our cannabis oral strips meet a rising, unmet demand for alternative and safe routes of cannabis administration that achieve optimal potency and higher bioavailability,” concluded Zacharin. “Consumers deserve to have the confidence that the next time they go to use cannabis they are not going to end up dead in the emergency room. Our products are helping shift consumer behavior into a safer, alternative method of administration that places dose standardization, efficacy, and most importantly, safety at the forefront of cannabis use”.
Zacharin’s appearance on the Yahoo Finance News Network follows several recent advancements by the Company, including its planned manufacturing and foray into the European market, as well as plans to conduct a new study on its technology’s cannabinoid absorption in partnership with an Israeli academic research center.
Our technology was created by an experienced team of scientists over a decade ago. Our product, a bio-adhesive, adjustable dose, fully dissolvable and non-irritant patch, is designed to accelerate and enhance the delivery and bioavailability of medicines and cannabis actives when compared to traditional methods of administration. The Company combines this with expertise and innovation in concept development to full-scale commercialization. The oral strip product comes in many great tasting flavors, and is designed to meet the demands of cannabis consumers.
About Yahoo Finance
Yahoo! Finance is a media property that is part of Yahoo!'s network. It provides financial news, data and commentary including stock quotes, press releases, financial reports, and original content. It also offers some online tools for personal finance management. In addition to posting partner content from a wide range of other web sites, it posts original stories by its team of staff journalists. As of June 2017, Yahoo Finance is part of Oath, the media division of Verizon. It is the largest business news website in the United States by monthly traffic.
About The Greater Cannabis Company
The Greater Cannabis Company (OTC: GCAN) is a biopharmaceutical company focused on the development and commercialization of innovative cannabinoid delivery systems. Greater Cannabis deploys its patented technology platform for use in the cannabis industry. The Company’s conveyance platform can be utilized to deliver cannabinoids without the harmful side effects found with other routes of cannabinoid administration. The technology is versatile in that for the first-time patients can receive lower dosing, enhanced bioavailability, and controlled rapid and delayed release using a fully dissolvable, non-irritant oral eluting patch. Greater Cannabis’ mission is to bring our technology to the global market through partnerships with leading cannabis and pharmaceutical companies, for the benefit of patients and consumers. More information on the Greater Cannabis Company and its technology can be found on the Company’s website, www.gcanrx.com.
Disclaimer: GCANRx relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the company’s best judgment based upon current information and involve several risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identified from time to time in the company’s public announcements.
###
Contact:
The Greater Cannabis Company, Inc.
443-738-4051
info@gcanrx.com